X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Unichem Lab with Aurobindo Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs AUROBINDO PHARMA - Comparison Results

AUROBINDO PHARMA 
   Change

Aurobindo Pharma is one of India's top 5 pharma companies in terms of turnover, and has presence in the generic and Active Pharmaceutical Ingredients (API) segments. The company's robust product portfolio is spread across 6 product areas, including a... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    UNICHEM LAB AUROBINDO PHARMA UNICHEM LAB/
AUROBINDO PHARMA
 
P/E (TTM) x 22.6 17.9 125.8% View Chart
P/BV x 2.4 5.8 40.8% View Chart
Dividend Yield % 0.8 0.4 224.8%  

Financials

 UNICHEM LAB   AUROBINDO PHARMA
EQUITY SHARE DATA
    UNICHEM LAB
Mar-16
AUROBINDO PHARMA
Mar-16
UNICHEM LAB/
AUROBINDO PHARMA
5-Yr Chart
Click to enlarge
High Rs3341,541 21.7%   
Low Rs174582 29.9%   
Sales per share (Unadj.) Rs146.9237.5 61.9%  
Earnings per share (Unadj.) Rs11.933.9 35.1%  
Cash flow per share (Unadj.) Rs16.240.6 39.9%  
Dividends per share (Unadj.) Rs2.002.50 80.0%  
Dividend yield (eoy) %0.80.2 334.3%  
Book value per share (Unadj.) Rs105.1120.6 87.2%  
Shares outstanding (eoy) m90.84585.17 15.5%   
Bonus/Rights/Conversions ESOPPREF-  
Price / Sales ratio x1.74.5 38.7%   
Avg P/E ratio x21.431.3 68.2%  
P/CF ratio (eoy) x15.726.2 60.0%  
Price / Book Value ratio x2.48.8 27.5%  
Dividend payout %16.87.4 227.8%   
Avg Mkt Cap Rs m23,073621,041 3.7%   
No. of employees `0005.713.3 42.7%   
Total wages/salary Rs m2,55815,508 16.5%   
Avg. sales/employee Rs Th2,352.510,457.6 22.5%   
Avg. wages/employee Rs Th450.91,167.1 38.6%   
Avg. net profit/employee Rs Th190.41,491.6 12.8%   
INCOME DATA
Net Sales Rs m13,346138,961 9.6%  
Other income Rs m1921,663 11.5%   
Total revenues Rs m13,538140,624 9.6%   
Gross profit Rs m1,63932,056 5.1%  
Depreciation Rs m3903,926 9.9%   
Interest Rs m292,568 1.1%   
Profit before tax Rs m1,41227,225 5.2%   
Minority Interest Rs m039 0.0%   
Prior Period Items Rs m-40-   
Extraordinary Inc (Exp) Rs m-350-   
Tax Rs m2937,444 3.9%   
Profit after tax Rs m1,08019,820 5.5%  
Gross profit margin %12.323.1 53.2%  
Effective tax rate %20.727.3 75.8%   
Net profit margin %8.114.3 56.8%  
BALANCE SHEET DATA
Current assets Rs m5,979100,015 6.0%   
Current liabilities Rs m2,43274,759 3.3%   
Net working cap to sales %26.618.2 146.3%  
Current ratio x2.51.3 183.8%  
Inventory Days Days63107 58.7%  
Debtors Days Days60110 55.1%  
Net fixed assets Rs m6,40352,350 12.2%   
Share capital Rs m182585 31.0%   
"Free" reserves Rs m9,29367,707 13.7%   
Net worth Rs m9,54870,567 13.5%   
Long term debt Rs m2308,472 2.7%   
Total assets Rs m12,843156,994 8.2%  
Interest coverage x50.011.6 431.2%   
Debt to equity ratio x00.1 20.1%  
Sales to assets ratio x1.00.9 117.4%   
Return on assets %8.614.3 60.6%  
Return on equity %11.328.1 40.3%  
Return on capital %14.337.7 38.0%  
Exports to sales %29.251.0 57.2%   
Imports to sales %6.318.8 33.7%   
Exports (fob) Rs m3,90070,927 5.5%   
Imports (cif) Rs m84726,193 3.2%   
Fx inflow Rs m4,35671,015 6.1%   
Fx outflow Rs m1,16228,799 4.0%   
Net fx Rs m3,19442,216 7.6%   
CASH FLOW
From Operations Rs m1,11917,596 6.4%  
From Investments Rs m-853-13,801 6.2%  
From Financial Activity Rs m-334-198 168.5%  
Net Cashflow Rs m-683,597 -1.9%  

Share Holding

Indian Promoters % 50.1 54.1 92.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 15.1 8.0 189.9%  
FIIs % 3.0 27.7 10.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 31.7 10.2 310.8%  
Shareholders   20,176 69,601 29.0%  
Pledged promoter(s) holding % 0.0 8.6 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare UNICHEM LAB With:   STERLING BIOTECH  PFIZER  ALKEM LABORATORIES  ORCHID PHARMA LTD  SANOFI INDIA  

Compare UNICHEM LAB With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Flat Note; Coal India Stock Rallies 4.2%(Closing)

Indian share markets finished some selling pressure in the final hour of trade to finish flat amid weak European markets.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

Proxy Plays: A Smart Way to Bet on 'Off Limits' Companies(The 5 Minute Wrapup)

Aug 4, 2017

The small-cap space is full of small players that are clear proxies to great growth stories and Indian megatrends.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

UNICHEM LAB SHARE PRICE


Aug 17, 2017 03:37 PM

TRACK UNICHEM LAB

  • Track your investment in UNICHEM LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

UNICHEM LAB 8-QTR ANALYSIS

COMPARE UNICHEM LAB WITH

MARKET STATS